Potential mitigating impact of a dipeptidyl peptidase-IV inhibitor, vildagliptin, on oxazolone-induced ulcerative colitis: Targeting the role of PI3K/AKT/mTOR and AMPK/Nrf2 signaling pathways
Article in International Immunopharmacology (April 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in International Immunopharmacology (April 2024)
Article in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (January 2024)
Article in Pharmaceutics (July 2023)